251. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis
- Author
-
Naoyuki Tsukada, K. Miyagi, Nobuo Yanagisawa, and Masayuki Matsuda
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Multiple Sclerosis ,Exacerbation ,Adolescent ,Intercellular Adhesion Molecule-1 ,Enzyme-Linked Immunosorbent Assay ,Receptors, Tumor Necrosis Factor ,Cerebrospinal fluid ,Antigen ,Recurrence ,medicine ,Humans ,ICAM-1 ,Cell adhesion molecule ,business.industry ,Multiple sclerosis ,Osmolar Concentration ,Middle Aged ,medicine.disease ,Solubility ,Tumor necrosis factor alpha ,Female ,Neurology (clinical) ,business ,Cell Adhesion Molecules - Abstract
We investigated the presence of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble tumor necrosis factor receptor (sTNF-R) antigens in the CSF of patients with multiple sclerosis (MS) using a double-determinant ELISA. Patients with acute relapsing MS during an exacerbation (p0.001) and those with chronic progressive MS (p0.001) had significantly increased CSF levels of sICAM-1 compared with subjects with other neurologic diseases. CSF levels of sTNF-R were also significantly increased in patients with acute relapsing MS during an exacerbation (p0.001) and chronic progressive MS (p0.001) compared with subjects with other neurologic diseases. CSF levels of sICAM-1 and sTNF-R were positively correlated in patients with acute relapsing MS during an exacerbation (r = 0.81, p0.01) and chronic progressive MS (r = 0.86, p0.001). These results suggest that active immune reactions involving ICAM-1 and TNF-R production are present within the CNS and that both sICAM-1 and sTNF-R are important immunologic markers of the clinical activity of MS.
- Published
- 1993